MDGL CIK: 1157601

Madrigal Pharmaceuticals Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
0
FY23:
0
FY24:
174
FY25:
902
(positive)
Change from FY21 to FY25
millions USD
FY21:
−242
FY22:
−294
FY23:
−380
FY24:
−504
FY25:
−356
(positive)
Change from FY21 to FY25
millions USD
FY21:
−241
FY22:
−291
FY23:
−360
FY24:
−450
FY25:
−262
(positive)
Change from FY21 to FY25
millions USD
FY21:
−242
FY22:
−295
FY23:
−374
FY24:
−466
FY25:
−288
(positive)
Change from FY21 to FY25
millions USD
FY21:
−242
FY22:
−295
FY23:
−374
FY24:
−466
FY25:
−288

All amounts in millions USD Data sources:SEC EDGARTwelve Data